TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05261217

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: The motion 3D II appliance
Description: The motion 3D II appliance treating class II malocclusion
Study: NCT00245063

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pharmacogenomic studies
Description: Optional correlative studies
Study: NCT02339649

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Blood Sample
Description: Blood Sample

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Blood Sample
Description: Blood Sample

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Blood Sample
Description: Blood Sample

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Neurocognitive Assessment
Description: Neurocognitive Assessment

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Neurocognitive Assessment
Description: Neurocognitive Assessment

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Neurocognitive Assessment
Description: Neurocognitive Assessment
Study: NCT04630054

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Face mask
Description: Intervention individuals will be given cloth or surgical face masks.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Face mask awareness
Description: Intervention individuals will be told about the importance of wearing face masks that cover the nose, mouth, and chin. Mask by mask promoters and community and religious leaders will encourage mask wearing.
Study: NCT02812004

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Ultra Q Reflex YAG laser (Ellex)
Description: Group 1 receives up to 2 sessions of vitreolysis performed with the Ultra Q Reflex YAG laser (Ellex). There is no cut off for total energy per treatment session.~For the sham treatment in group 2, the physician quickly manipulates the light switch of the laser's slit lamp to create light flashes and simulate laser pulses.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ultra Q Reflex YAG laser (Ellex)
Description: Group 1 receives up to 2 sessions of vitreolysis performed with the Ultra Q Reflex YAG laser (Ellex). There is no cut off for total energy per treatment session.~For the sham treatment in group 2, the physician quickly manipulates the light switch of the laser's slit lamp to create light flashes and simulate laser pulses.
Study: NCT04756544

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lactobacillus helveticus Rosell®-52, Bifidobacterium longum Rosell®-175
Description: probiotic

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lactobacillus helveticus Rosell®-52, Bifidobacterium longum Rosell®-175
Description: probiotic

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo
Study: NCT00839111

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sorafenib
Description: Sorafenib 400mg twice daily from d3 to d14,d17-28

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FOLFIRI
Description: Irinotecan 180 mg/m2,CF 400mg/m2 5Fu 400mg/m2 bolus, followed by 2.4g/m2 continuously intravenous infusion for 46 hours, days 1 and 15, every 4 weeks per cycle
Study: NCT03582358

Intervention type: OTHER
Intervention: Food weighing
Description: Quantification of food intake over three consecutive days (D5, D6 and D7 then D26, D27 and D28) by weighing the food served and the leftovers at and after mealtimes.

Intervention type: OTHER
Intervention: Food weighing
Description: Quantification of food intake over three consecutive days (D5, D6 and D7 then D26, D27 and D28) by weighing the food served and the leftovers at and after mealtimes.
Study: NCT01729689

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: counseling intervention
Description: Undergo cognitive behavioral therapy

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: questionnaire administration
Description: Ancillary studies

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: quality-of-life assessment
Description: Ancillary studies
Study: NCT02049502

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: biologically active human fecal microbiota
Description: instillation of biologically active human fecal microbiota material via flexible sigmoidoscopy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: sigmoidoscopy
Study: NCT04176861

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: home-based Brainwave Entrainment Technology
Description: Smartphone app-based brainwave entrainment programme using audio stimulation via binaural beats or visual stimulation via flickering lights
Study: NCT03449888

Intervention type: PROCEDURE
Intervention: Regadenoson myocardial perfusion imaging stress test
Description: Best fit model of pharmacologic myocardial perfusion imaging data, including summed stress and difference scores, gated left ventricular ejection fraction, transient ischemic dilatation, and heart rate response to regadenoson data.

Intervention type: PROCEDURE
Intervention: Arm exercise electrocardiographic stress test
Description: Published arm exercise score and best fit model of arm exercise ECG stress testing data.

Intervention type: PROCEDURE
Intervention: Treadmill electrocardiographic stress test
Description: Duke Treadmill Score and best fit model of treadmill exercise ECG stress testing data.

Intervention type: PROCEDURE
Intervention: Coronary artery calcium score and cardiac computed tomographic angiography
Description: Coronary artery calcium score by Agatston criteria and severe obstructive coronary artery disease \> 70% by cardiac computed tomographic angiography or invasive coronary arteriography.
Study: NCT04358393

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: APG-115
Description: APG-115 given once daily on day 1-5 of every 28 day cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: APG-115
Description: APG-115 given once daily on day 1-5 of every 28 day cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-azacitidine
Description: 5-AZA is given at 75 mg/m˄2/d subcutaneously daily on Day 1-7 every 28 days
Study: NCT01849133

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: external fractionated radiotherapy
Description: conventional external beam radiotherapy

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: intraoperative radiotherapy
Description: Intraoperative radiotherapy (IORT). Total delivered dose 21Gy (Gray), 90% isodose
Study: NCT02053688

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Astigmatic Correction Lens (Nexis ACCL lenses)
Description: Astigmatic refractive error correction

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Toric Soft Contact Lenses
Description: astigmatism correction using toric optics
Study: NCT01312194

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Root canal therapy in one visit
Description: Patient was anesthetized with local anesthetic solutions, and the caries was removed. The tooth was isolated with rubber dam and access to pulp chamber was completed. Cleaning and shaping preparation was achieved with manual and rotatory endodontic instruments.The ideal working length was determined by an electronic apex locator and periapical radiography. Irrigation was performed with 5.25%NaOCl solution. The smear layer was removed by 10% citric acid. The cases were obturated with guta-percha cones using a lateral compaction filling technique as well as zinc oxide-eugenol-based root canal sealer. The teeth filled with a light-cured resin.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Root Canal Therapy in two-vist
Description: The treatment protocol was the same as described for one visit group. In the first visit, after cleaning, shaping and smear layer removal, the root canals were medicated with a calcium hydroxide paste and sterile distilled water (1:1) and the pulp chamber was sealed with a minimum 3mm thickness temporary filling restoration. After 10-12 days, during the second visit, the medication was removed, and the cases were obturated with guta-percha cones using a lateral compaction filling technique as well as zinc oxide-eugenol-based root canal sealer. The teeth filled with a light-cured resin.
Study: NCT00403104

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ONO-2506PO
Description: 1200 mg QD / 18 months

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: ONO-2506PO
Description: 0 mg QD / 18 months
Study: NCT03031561

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ultrasound
Description: Undergo standard ultrasound

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MicoPure ultrasound
Description: Undergo MicoPure ultrasound

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy of Breast
Description: Undergo breast biopsy or surgical resection
Study: NCT02339649

Intervention type: OTHER
Group type: OTHER
Intervention: Resting State EEG
Description: 10-20 Minutes of Resting State EEG
Study: NCT02858479

Intervention type: OTHER
Group type: OTHER
Intervention: stimulation on painful area (area allodynic)
Description: these stimulations will be performed either with a brush, with a cold block or with forced air (cold air or air to ambient temp) : calibrated to induce pain bearable.~stimulations for 6 seconds

Intervention type: OTHER
Group type: OTHER
Intervention: stimulation on painful area (area allodynic)
Description: these stimulations will be performed either with a brush, with a cold block or with forced air (cold air or air to ambient temp) : calibrated to induce pain bearable.~stimulations for 6 seconds

Intervention type: OTHER
Group type: OTHER
Intervention: same stimulation on non-painful area
Description: these stimulations will be performed either with a brush, with a cold block or with forced air (cold air or air to ambient temp) : calibrated to induce pain bearable.~stimulations for 6 seconds

Intervention type: OTHER
Group type: OTHER
Intervention: same stimulation on non-painful area
Description: these stimulations will be performed either with a brush, with a cold block or with forced air (cold air or air to ambient temp) : calibrated to induce pain bearable.~stimulations for 6 seconds

Intervention type: RADIATION
Group type: OTHER
Intervention: MRI scan
Description: 2 sessions for 10 minutes :~* 11 controls stimulations for 6 s each spaced 20 s without stimulation.~* 11 allodynic stimulations for 6 s each spaced 20 s without stimulation.

Intervention type: RADIATION
Group type: OTHER
Intervention: MRI scan
Description: 2 sessions for 10 minutes :~* 11 controls stimulations for 6 s each spaced 20 s without stimulation.~* 11 allodynic stimulations for 6 s each spaced 20 s without stimulation.
Study: NCT01217281

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Full Mouth Non-Surgical Periodontal Therapy
Description: Non-surgical Periodontal Therapy provided in two sessions, one for the right half and one for the left half of the dentition. Treatment sessions are provided within one week. No antibiotics or other adjunctive medications are to be used
Study: NCT01305915

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Getting Back on Track
Description: The intervention, entitled Getting Back on Track, is two hours in duration and delivered by a multidisciplinary team representing nursing, radiation therapy, social work, rehabilitation services, and nutrition from the Breast Cancer Clinic at Princess Margaret Hospital. Relying on the content of the Getting Back on Track booklet, clinical experience and the principles of adult education, this team developed scripts for each component of the class.
Study: NCT01328873

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Microbiological analysis
Description: Bronchoalveolar lavage (BAL) with subsequent testing for pathogens
Study: NCT00584662

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxymetazoline Hydrochloride
Description: Oxymetazoline Hydrochloride TWO SPRAYS BID
Study: NCT02291159

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DNHS ® (Dry Needling for Hypertonia and Spasticity)
Description: Dry needling of Myofascial Trigger Points. 2 sessions, one per week, in biceps brachii, brachialis, flexor digitorum superficialis nad profundus, adductor pollicis and first dorsal interossei

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Dry Needling
Description: Sham dry needling of Myofascial Trigger Points. 2 sessions, one per week, in biceps brachii, brachialis, flexor digitorum superficialis nad profundus, adductor pollicis and first dorsal interossei
Study: NCT02495363

Intervention type: PROCEDURE
Intervention: PECS Block
Description: As standard departmental protocol ultrasound guided PECS Block will be performed by identifying the thoracic muscles. Following the identification, the investigator will inject the anesthetic solution which will contain the conventional 25 cc of Bupivacaine 0.25-0.5% .~The concentration is determined by the upper dose limit to 2 mg / kg 11

Intervention type: DRUG
Intervention: Bupivacaine 0.25-0.5%
Description: Ultrasound guided PECS Block will be performed by identifying the thoracic muscles. Following the identification, the investigator will inject the anesthetic solution which will contain the conventional 25 cc of Bupivacaine 0.25-0.5% .~The concentration is determined by the upper dose limit to 2 mg / kg 11
Study: NCT04226352

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dextromethorphan
Description: Dextromethorphan will be administered and its tolerability evaluated.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dextromethorphan
Description: Dextromethorphan will be administered and its tolerability evaluated.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dextromethorphan
Description: Dextromethorphan will be administered and its tolerability evaluated.
Study: NCT01658800

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VAX161C vaccine
Description: Recombinant H5 influenza vaccine, VAX161C
Study: NCT02587494

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Cardiac catheterization
Description: Cardiac catheterization / coronary angiography is a diagnostic procedure used to define the coronary anatomy and presence of obstructive coronary lesions or culprit lesions. According to the findings, it may lead to percutaneous coronary intervention (PCI) using stents
Study: NCT01656239

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fedovapagon 1 mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fedovapagon 2 mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fedovapagon 4 mg

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo ( sugar pill)
Study: NCT00986336

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: topiramate
Description: 1-25 mg plus 1-100 mg tablet twice daily for 2 weeks (250 mg/day)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: topiramate
Description: 2-100 mg tablets twice daily for 2 weeks (400 mg/day)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: risperidone
Description: Twice daily, individualized dosing to stabilization at 1-6 mg/day.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: topiramate
Description: 2-25 mg tablets twice daily for 2 weeks (100 mg/day)
Study: NCT04761185

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Raltitrexed
Description: Raltitrexed in HIPEC
Study: NCT02339649

Intervention type: OTHER
Group type: OTHER
Intervention: Resting State EEG
Description: 10-20 Minutes of Resting State EEG

Intervention type: OTHER
Group type: OTHER
Intervention: Resting State EEG
Description: 10-20 Minutes of Resting State EEG
Study: NCT02593370

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocaine-epinephrine added gadoterate meglumine

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine-epinephrine added gadoterate meglumine
Study: NCT04205123

Intervention type: GENETIC
Intervention: sickle cell syndrome
Description: Academic Study prospective multicenter observational factors responsible for nephropathy in patients with sickle cell disease followed by Belgium and the Nord-Pas -De- Calais Region and creating a biobank of blood and urine.~In the population of patients with SCD followed in all participating centres.~Know the prevalence of nephropathy and the relationship between it with their some of their genotypic mutations and clinical phenotype promoting mutated hemoglobin polymerization.~Determine the behaviour of dense cells in the basal state and in a hypeosmolaire environment~Determine the place of the erythrocyte microparticles as a biomarker of sickle cell nephropathy~Studying genes known as risk factor for proteinuria~Create a BioBank of samples of sickle cell patients in clinically stable condition for other research purposes.
Study: NCT01566721

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Herceptin
Description: Herceptin will be given as 600 mg SC (into thigh) on Day 1 of each 3-week cycle for up to 18 cycles.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Herceptin
Description: Herceptin will be given as 600 mg SC (into thigh) on Day 1 of each 3-week cycle for up to 18 cycles.
Study: NCT04908098

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: diode laser
Description: It is the application of the laser tip parallel to the inner surface of the periodontal pocket

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: scaling - root planning
Description: Scaling is the removal of calculus and other deposits in the root of the tooth.Root planning is the removal of necrotic cementum on the tooth root surface. Scaler and gracey curettes are used for these operations.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: scaling - root planning
Description: Scaling is the removal of calculus and other deposits in the root of the tooth.Root planning is the removal of necrotic cementum on the tooth root surface. Scaler and gracey curettes are used for these operations.
Study: NCT03726892

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: PCI
Description: Coronary Intervention

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: PCI
Description: Coronary Intervention
Study: NCT04093245

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: GEM nurse
Description: hospital-based geriatric emergency nurse (GEM nurse) specialist to support patients during the post-discharge transition period

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: GEM nurse
Description: hospital-based geriatric emergency nurse (GEM nurse) specialist to support patients during the post-discharge transition period

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: pre- and post-hospitalization medication list reconciliation
Description: pre- and post-hospitalization medication list reconciliation for elderly

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: pre- and post-hospitalization medication list reconciliation
Description: pre- and post-hospitalization medication list reconciliation for elderly
Study: NCT04599985

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: star excursion balance training (SEBT)
Description: The SEBT is aimed to be maintained the single limb stance on one leg while reaching farthest possible with the swing leg. An individual can reach farthest with the swing leg while maintaining the balance on the stance leg

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Simplified star excursion balance training (SSEBT)
Description: It is one of the training protocols, in a simplified way, with respect to star excursion balance test. It consists a series of reaching tasks for the lower limbs in three-directions i.e., anteromedial, medial and posteromedial.
Study: NCT04093245

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: systematic discharge summaries
Description: systematic discharge summaries given to patients and/or caregiver, and sent to their family physician

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: systematic discharge summaries
Description: systematic discharge summaries given to patients and/or caregiver, and sent to their family physician

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: medical follow-up appointment
Description: a planned follow-up appointment with their family physician

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: medical follow-up appointment
Description: a planned follow-up appointment with their family physician

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: follow-up phone call
Description: a systematic follow-up phone call for discharged patients

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: follow-up phone call
Description: a systematic follow-up phone call for discharged patients

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Wiki-based Knowledge tools
Description: access to wiki-based patient-oriented KT tools

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Wiki-based Knowledge tools
Description: access to wiki-based patient-oriented KT tools

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telemonitoring service
Description: access to a community-based telemonitoring service

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telemonitoring service
Description: access to a community-based telemonitoring service
Study: NCT04084197

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HIP1402
Description: Tamsulosin (HanmiTams Capsule) 0.4mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HIP1402
Description: Tamsulosin (HanmiTams Capsule) 0.4mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HIP1402
Description: Tamsulosin (HanmiTams Capsule) 0.4mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HIP1402
Description: Tamsulosin (HanmiTams Capsule) 0.4mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HIP1801
Description: Tamsulosin 0.4mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HIP1801
Description: Tamsulosin 0.4mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HIP1801
Description: Tamsulosin 0.4mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HIP1801
Description: Tamsulosin 0.4mg
Study: NCT00096447

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: lapatinib ditosylate
Study: NCT04430985

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: Day 1 in cycle 1-4: 100 mg/m2 intrahepatic administration Day 1 in cycle 5-8: oxaliplatin 85 mg/m2 i.v.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-Fluorouracil
Description: Day 1 each cycle: 400 mg/m2 i.v. bolus, 2400 mg/m2 i.v.over 46 hrs

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Leucovorin
Description: Day 1 each cycle: 400 mg/m2 i.v.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Day 3 in cycle 3 to 8: 3 mg/kg i.v.
Study: NCT03172000

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Colonoscopy and biopsy
Description: Colonoscopic biopsy were taken from the rectum, the sigmoid, descending, transverse, ascending colon, and the cecum of each patient.